[An experimental study on prednisolone-induced interstitial pneumonia caused by Pneumocystis carinii].
This study was performed to observe the role of Pneumocystis carinii as an etiologic agent of interstitial pneumonia in immunocompromised hosts. Total 90 male Sprague-Dawley rats, approximately 150-180 g, were used. Fifteen of them were used as control group and remaining 75 (5 groups) were as immunosuppression groups; group 1 received prednisolone (25 mg/kg twice weekly) only; group 2 prednisolone and tetracycline (75 mk/kg/day); group 3 prednisolone, tetracycline and trimethoprim-sulfamethoxazole (50-250 mg/kg/day); group 4 prednisolone and trimethoprimsulfamethoxazole; and group 5 prednisolone and griseofulvin (300 mg/kg/day) until death. The survival days of each group rat were calculated, and upon death their lungs were removed immediately and then stamp smears were prepared and stained by Giemsa or toluidine blue O. For histopathologic observation, lungs were fixed in 10% formalin, cut into sections and stained with Gomori's methenamine silver, hematoxylin-eosin, and Brown & Brenn stain. The results obtained were as follows: 1. The mean survival time of each group rat was 19.3 +/- 5.2 days (group 1), 41.1 +/- 14.0 days (group 2), 50.5 +/- 18.4 days (group 3), 43.0 +/- 22.9 days (group 4) or 21.8 +/- 5.1 days (group 5). Significant differences were noted between group 1 and group 2(p less than 0.01), group 1 and group 3 (p less than 0.01), and group 1 and group 4 (p less than 0.01), which represented bacterial infections were most fatal in immunocompromised rats.(ABSTRACT TRUNCATED AT 250 WORDS)
Shin
D W
DW
Lee
Y H
YH
Na
Y E
YE
D000818:Animals; D007108:Immune Tolerance / Q000187:drug effects*; D008297:Male; D011020:Pneumonia, Pneumocystis; D011239:Prednisolone / Q000009:adverse effects*; D011658:Pulmonary Fibrosis / Q000209:etiology* / Q000382:microbiology; D051381:Rats; D011919:Rats, Inbred Strains
D011239:Prednisolone